首页> 外文期刊>Cytopathology >Estimation of disease severity in the NHS cervical screening programme. Part II: quantitative methods of estimating disease severity and progression potential.
【24h】

Estimation of disease severity in the NHS cervical screening programme. Part II: quantitative methods of estimating disease severity and progression potential.

机译:在NHS子宫颈筛查计划中估算疾病的严重程度。第二部分:估计疾病严重程度和进展潜力的定量方法。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: This is the second of a two-part paper exploring the use of a more quantitative approach to both cytology and histology disease severity measurements. In Part I the problem of artificial cut-off points was discussed and a semi-quantitative solution to the problem proposed. In Part II quantitative methods are proposed that are used to predict the estimated progression probability (EPP) to invasive cancer. METHODS: Based on models derived from published data the grade number (GN) is related to the EPP to invasive cancer over the next 10 years for both cytology (CEPP) and histology (HEPP) using a look-up table. CEPP and HEPP are then adjusted by other factors such as age, persistence, HPV result, number of cells and lesion size to obtain the adjusted CEPP and HEPP (ACEPP and (AHEPP). The two factors can be combined to produce an adjusted weighted estimated progression potential using the formula AWEPP radical((ACEPP + AHEPP)/2) x AHEPP) using a two to one bias in favour of the histology. RESULTS: As an example of the methodology consider a slide estimated as showing a 60% probability of moderate dyskaryosis (HSIL favouring CIN2) and 40% probability of mild dyskaryosis (LSIL favouring CIN1). The GN number would be 1.6 (as described in Part I) and the EPP over the next 10 years 0.78%. For a woman aged 52 years (correction factor x2.0) with a second mildly dyskaryotic smear (correction factor x1.25) and >50 dyskaryotic cells (correction factor 1.5) the ACEPP would be 0.78 x 2.00 x 1.25 x 1.5 = 2.9%. If the HEPP on histology was 50:50 between CIN1 and CIN2, the AHEPP can be calculated as 1.4%. The AWEPP would be radical((2.9 + 1.4)/2 x 1.4) = 1.7%. The final estimate of disease progression potential based on both cytology and histology is 1.7% over 10 years. CONCLUSIONS: These quantitative approaches based on adjusted and weighted EPP provide a framework suitable for research, audit and comparison between screening centres, and for tailoring criteria for colposcopy referral and treatment. Further research is required to improve the estimates given in the paper.
机译:目的:这是由两部分组成的论文的第二篇,探讨了使用更定量的方法进行细胞学和组织学疾病严重性测量。在第一部分中,讨论了人工截止点的问题,并提出了该问题的半定量解决方案。在第二部分中,提出了定量方法,用于预测向浸润性癌症的估计进展概率(EPP)。方法:基于公开数据得出的模型,使用查找表,在接下来的10年中,细胞学(CEPP)和组织学(HEPP)的等级数(GN)与侵袭性癌症的EPP相关。然后通过年龄,持续性,HPV结果,细胞数和病变大小等其他因素调整CEPP和HEPP,以获得调整后的CEPP和HEPP(ACEPP和(AHEPP)),可以将这两个因素结合起来以产生调整后的加权估计值使用公式AWEPP自由基((ACEPP + AHEPP)/ 2)x AHEPP)使用2到1偏向于组织学的分子来获得潜在的进展。结果:作为该方法的一个例子,考虑一张幻灯片,该幻灯片估计显示出60%的中度运动障碍(HSIL偏爱CIN2)和40%的轻度运动(LSIL偏爱CIN1)。未来十年,GN数将为1.6(如第一部分所述),EPP为0.78%。对于52岁(校正系数x2.0),第二次轻度营养不良涂片(校正系数x1.25)和> 50个营养不良细胞(校正系数1.5)的女性,ACEPP为0.78 x 2.00 x 1.25 x 1.5 = 2.9% 。如果组织学上的HEPP在CIN1和CIN2之间为50:50,则AHEPP可以计算为1.4%。 AWEPP将是激进的((2.9 + 1.4)/ 2 x 1.4)= 1.7%。基于细胞学和组织学的疾病发展潜力的最终估计是在10年中达到1.7%。结论:这些基于调整后的加权EPP的定量方法提供了一个框架,适用于筛查中心之间的研究,审核和比较,以及适合阴道镜转诊和治疗的定制标准。需要进一步研究以改善本文给出的估计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号